monoclonal antibody
Samsung BioLogics To Manufacture Antibody Drug For Bristol-Myers Squibb
Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Myers Squibb at its Songdo Incheon plant in South Korea.
China’s Zongyi Group Invests In US-Based ContraFect Corporation
The Zongyi Group of China has invested US$8.6 million into US-based ContraFect Corporation as part of a US$9.5 million financing.
X-BODY, Jiangsu Hengrui To Develop Novel Therapeutic Antibodies
X-BODY Biosciences has signed an agreement with Jiangsu Hengrui to commercialize therapeutic antibodies for age-related macular degeneration.
Sanofi Pasteur, Xiamen University To Develop Universal Flu Vaccine
Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.
Simcere To Begin Clinical Trials On VEGF Inhibitor
Simcere Pharma has received SFDA approval to begin first-in-man trials with its humanized monoclonal antibody candidate, APX003.
A*STAR Scientists Target Intracellular Oncoprotein With Antibodies
A*STAR scientists have used antibodies to target proteins within the cancer cell which were previously thought to be inaccessible.
